Development of a knowledgebase to enable streamlined analysis and interpretation of NGS data from pediatric leukemia cohorts

Twenty years ago, the first human genome was sequenced at a cost of 3 billion dollars. Today, this can be done in a day at a cost of approximately $1000. Despite this drastic reduction, the promise of personalized medicine, to customize therapy for each patient, has not yet been realized through next generation sequencing (NGS). […]

Read More